Sandro Mamukelashvili aims to enhance Lakers' shooting this summer
Yahoo Sports • 1 min read • Latest: Jul 16, 2026, 3:26 AM
Last updated Jul 16, 2026
Sandro Mamukelashvili spoke about his plans to shoot extensively this summer after signing a four-year, $52 million contract with the Los Angeles Lakers. He expressed enthusiasm for playing alongside Luka Doncic and aims to improve the Lakers' 3-point shooting, an area where they struggled last season. Mamukelashvili averaged 11.2 points and nearly 39% shooting from beyond the arc last season, contributing to what the Lakers hope will be an improved roster. The decision on whether he will start or come off the bench remains to be determined as the 2026-27 campaign approaches.
- •Sandro Mamukelashvili signed a four-year, $52 million contract with the Lakers.
- •He averaged 11.2 points and shot 38.9% from three last season.
- •Mamukelashvili aims to complement Luka Doncic's offensive play.
- •The Lakers were 14th in 3-point accuracy last season.
- •His role as a starter or bench player for the upcoming season is undecided.
- 3:26 AMYahoo Sports — Sandro Mamukelashvili says he will 'shoot a million 3s' this summer
"New Lakers big man Sandro Mamukelashvili sounds motivated and ready to complement Luka Doncic offensively.
Sources
External linksOriginal reporting and copyright belong to the linked sources. SportsNewsReport.com aggregates and links — it does not republish full articles.
Related Stories
Last 14 days
NBA•Sep 6, 2026, 8:38 AMMatt Barnes on L.A.'s roster: 'Whitest Laker team since the Minneapolis Lakers'
NBA•Sep 6, 2026, 8:38 AM“But again, man, when you’ve got Luka and AR [Austin …
NBA•Sep 6, 2026, 6:06 AMDerek Fisher is confident the Lakers won't decline much without LeBron- NBA•Sep 6, 2026, 5:48 AMLuka Doncic's leadership for the Los Angeles Lakers gets a spotlight from Collin Sexton
- NBA•Sep 6, 2026, 4:50 AMMulti-time champion Danny Green gives his honest take on the new-look Lakers roster
NBA•Sep 6, 2026, 4:36 AMJosh Okogie Perfectly Compares LeBron James To Marvel’s Doctor Strange
